Patents by Inventor Eike-Roman Hrincius

Eike-Roman Hrincius has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and peptides for preventing and treating a BCR-ABL and a C-ABL associated disease
    Patent number: 9637523
    Abstract: The invention provides a combination of an isolated peptide or peptidomimetic that includes the sequence of SEQ ID NO: 1 or a homolog thereof, and an isolated peptide or peptidomimetic that includes the sequence of SEQ ID NO: 2. The invention also provides a method of treating a BCR-ABL associated disease or a c-ABL associated disease in a subject. The method is based on the use of the aforementioned combination of one or more isolated peptides or peptidomimetics.
    Type: Grant
    Filed: August 30, 2013
    Date of Patent: May 2, 2017
    Assignee: Westfaelische Wilhelms-Universitaet Muenster
    Inventors: Eike-Roman Hrincius, Stephan Ludwig, Christina Ehrhardt
  • Methods and Peptides for Preventing and Treating A BCR-ABL and a C-ABL Associated Disease
    Publication number: 20150218229
    Abstract: The invention provides a combination of an isolated peptide or peptidomimetic that includes the sequence of SEQ ID NO: 1 or a homolog thereof, and an isolated peptide or peptidomimetic that includes the sequence of SEQ ID NO: 2. The invention also provides a method of treating a BCR-ABL associated disease or a c-ABL associated disease in a subject. The method is based on the use of the aforementioned combination of one or more isolated peptides or peptidomimetics.
    Type: Application
    Filed: August 30, 2013
    Publication date: August 6, 2015
    Applicant: Westfaelische Wilhelms-Universitaet Muenster
    Inventors: Eike-Roman Hrincius, Stephan Ludwig, Christina Ehrhardt